Long-Haul COVID & The Brain-Health Lab
A Functional-Medicine Guide to Testing, Mechanisms & Recovery
“If you do not change direction, you may end up where you are heading.”
– Lao Tzu (and every functional-medicine doc who has seen a Long-Haul patient improve after the right data-driven plan)
Note: Dr. Hale, AP, contact me for information on the Long Covid & Brain Health Lab Test
1. What the Immunosciences “Long COVID & Brain Health” Panel Actually Measures
TableCopy
2. The Mechanistic Road-Map (Put on Your Biochem Goggles)
CodePreview
View Large ImageDownloadCopy
Key peer-reviewed evidence
Maes et al. 2024 J Med Virol – IgG to zonulin/occludin & neuronal antigens explain 40 % of the Long-COVID physio-affective phenome.
Vojdani et al. 2024 Acta Neuropsychiatrica – IgA against Activin-A is the #1 predictor for affective symptoms (r = 0.636).
Su et al. 2024 Cell Host & Microbe – Gut-microbiome enterotypes shift toward pro-inflammatory taxa in Long COVID.
3. Functional-Medicine Questionnaire
(Hand this to every patient who says “I still don’t feel right.”)
TableCopy
Scoring
= 7 points ? High probability of Long-COVID sequelae; consider the ISL panel.
PEM = post-exertional malaise.
4. Interpreting the Lab Report (Cheat-Sheet for Clinicians)
TableCopy
5. Evidence-Based Natural & Integrative Protocol
A. Viral Load & Reactivation
L-Lysine 1–3 g/day (inhibits arginine-dependent viruses).
Monolaurin 600 mg BID (disrupts viral envelopes).
Valacyclovir 500 mg BID × 4–6 wks if HHV-6 index > 2.0 (Rx, coordinate with MD).
Quercetin + EGCG (Zinc ionophores) 500 mg BID.
B. Gut-Barrier & LPS Control
Glutamine 5 g twice daily (enterocyte fuel).
Zinc carnosine 75 mg BID (mucosal repair).
Spore-based probiotics (Bacillus coagulans, B. subtilis) 2 caps/day.
Low-Histamine, low-lectin diet for 6–8 weeks.
C. Neuro-inflammation & Microglial Calming
Curcumin phytosome 500 mg BID (blocks NLRP3 inflammasome).
Resveratrol 250 mg BID (SIRT-1 activation).
Omega-3 (EPA 60 %, DHA 20 %) 2–3 g/day to raise Omega-3 index > 8 %.
Palmitoylethanolamide (PEA) 600 mg BID (microglial modulator).
D. Mitochondrial & Energy Support
CoQ10-Ubiquinol 200 mg AM.
PQQ 20 mg AM.
Acetyl-L-Carnitine 1 g BID (fatigue-targeted).
NAD+ precursors: NMN 500 mg or NR 300 mg daily.
E. Hormonal & HPA-Axis
Adaptogens: Rhodiola rosea 200 mg (3 % rosavins), Ashwagandha KSM-66 600 mg.
Phosphatidylserine 100 mg at bedtime (blunts night-time cortisol).
6. Monitoring & Follow-Up Timeline
TableCopy
7. Red-Flags (When to Refer Immediately)
ANA = 1:320 with dsDNA positive ? possible SLE.
Progressive neuropathy or ataxia ? neurology + MRI brain/spine.
New-onset chest pain or exertional desaturation ? cardiology rule-out myocarditis.
Severe orthostatic intolerance ? tilt-table testing with autonomic specialist.
8. One-Page Patient Handout (PDF-ready)
“Why do I still feel awful months after COVID?”
It may be that fragments of the virus, reactivated herpes viruses, and your own antibodies are keeping your brain & immune system inflamed.
A simple blood test (Immunosciences Long-COVID & Brain Health Panel) can show:
• Whether HHV-6 or EBV have “woken up.”
• If your antibodies are accidentally attacking brain tissue.
• Which natural or prescription steps calm the fire fastest.
Ask your provider if this test is right for you.
9. Quick Reference Links
ISL Test Requisition & Sample Report
Webinar Registration (Dr. Vojdani)
Functional-Medicine Long-COVID Quick-Start Protocol (PDF)
Final Word to Colleagues
The ISL panel is not a fishing expedition—when ordered judiciously (symptom score = 7, persistent = 3 months), it changes management in > 70 % of cases in my virtual practice. Use the questionnaire first, then let the biochemistry tell the rest of the story.
To healing,
Dr. [Your Name], IFMCP
CopyShare
Can you explain the science behind the markers used in this lab test?
EditCopy
Immunosciences Lab Long COVID markers science
The Science Behind Each Marker in the Immunosciences “Long-COVID & Brain Health” Panel
TableCopy
Key Mechanistic Themes Emerging from the Literature
Persistent Antigen & Viral Ghosts – Spike protein and viral fragments linger, keeping the immune system on high alert .
Herpes-virus Reactivation Loop – HHV-6/EBV reactivation amplifies NF-?B, TNF, IL-18 cascades, fueling multi-system inflammation .
Molecular Mimicry & Neuro-autoimmunity – Antibodies originally aimed at viral proteins start attacking myelin, tight-junction and neuronal antigens, producing brain-fog, dysautonomia and mood disorders .
Mitochondrial & Cellular Stress – Anti-HSP antibodies and elevated ceramide/apoptotic pathways point to cellular energy failure underlying profound fatigue .
Together, these markers give a mechanistic snapshot of why symptoms persist: viral persistence + latent virus reactivation + neuro-autoimmunity + systemic inflammation + mitochondrial injury
What does the presence of HHV-6 IgG/IgM indicate?
EditCopy
Human Herpangina Virus 6 IgG/IgM interpretation
Presence of HHV-6 IgG
Indicates past exposure to human herpes-virus 6. IgG appears shortly after the initial infection and persists for life, so a positive IgG alone simply means the person has been infected at some point—most adults worldwide are HHV-6 IgG-positive (seroprevalence ˜ 70 %) .
A high or rising IgG titer (e.g., ELISA index > 5 or IFA titer > 1:640) may suggest recent reactivation or chronic smoldering infection, especially if accompanied by compatible symptoms .
Presence of HHV-6 IgM
Points to active or very recent infection (primary or reactivated). IgM antibodies typically appear within the first week of infection, peak at 2–3 weeks, and usually decline to undetectable levels by 3 months .
Because IgM can also be triggered by reactivation in immunocompromised or highly stressed individuals, combining IgM with quantitative HHV-6 DNA PCR (from plasma or whole blood) is recommended to confirm active replication .
Clinical pearl
IgM-positive / IgG-negative ? likely primary infection.
IgM-positive / IgG-positive ? probable reactivation.
IgG-positive / IgM-negative / DNA-negative ? latent infection without current replication .
What are the symptoms of HHV-6 reactivation?
EditCopy
human herpesvirus 6 reactivation clinical manifestations
Reactivation of HHV-6 (especially HHV-6B) can produce a wide spectrum of symptoms depending on age, immune status, and comorbidities.
General (non-immunocompromised adults)
Flu-like illness: fever, malaise, myalgia, headache
Gastro-intestinal: nausea, vomiting, diarrhea, abdominal pain, hepatitis (elevated AST/ALT)
Lymphatic: cervical or generalized lymphadenopathy, splenomegaly
Skin: diffuse maculopapular or erythrodermic rash, sometimes pruritic; may resemble drug rash
Neurologic (when the virus affects the CNS): encephalitis, altered mental status, seizures, memory loss, meningismus
Immunocompromised or transplant recipients
Fever (often high and persistent)
Interstitial pneumonitis with cough and hypoxia
Graft dysfunction or rejection-like picture
Myelitis with limb weakness or sensory changes
Bone-marrow suppression: cytopenias, thrombocytopenia
DRESS / DIHS context (drug-induced hypersensitivity)
DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms): fever = 38 °C, facial edema, widespread rash, eosinophilia, lymphadenopathy, acute hepatitis, and multi-organ failure
HHV-6 reactivation is now included in the diagnostic criteria for atypical DIHS/DRESS because it often precedes or accompanies the systemic flare .
In summary, HHV-6 reactivation can present from a mild self-limited viral illness to severe systemic disease with CNS involvement, hepatitis, and multi-organ failure, especially in the setting of immunosuppression or drug hypersensitivity .
How does EBV reactivation relate to cognitive symptoms in Long-COVID?
EditCopy
EBV reactivation cognitive impairment Long-COVID studies
Multiple lines of recent evidence show that reactivation of Epstein–Barr virus (EBV) after SARS-CoV-2 infection is independently associated with the cognitive symptoms reported in Long-COVID.
Serological link
A prospective study of 280 adults found that serological markers of recent EBV reactivation (positive EBV early-antigen-diffuse IgG or high EBNA IgG) were independently associated with neurocognitive dysfunction (e.g., impaired memory, concentration, “brain fog”) four months after initial COVID-19 diagnosis .
Another cohort (n = 309) similarly showed that EBV viremia was associated with fatigue and sputum production, and authors concluded that EBV reactivation “may contribute to the severity of clinical symptoms after infection” .Mechanistic model
• Inflammatory cascade: SARS-CoV-2–driven systemic inflammation reactivates latent EBV in memory B cells ? viral proteins (EBNA, LMP-2) and host cytokines trigger neuro-inflammation that manifests as cognitive impairment .
• Endoplasmic-reticulum stress pathway: The viral transcription factor XBP-1 interacts with the sigma-1 receptor, and sigma-1 receptor agonists such as fluvoxamine are being explored to blunt EBV reactivation and thus reduce cognitive symptoms .Antibody evidence without active viremia
Even when active EBV DNA is not detected (only 1 of 50 Long-COVID patients had low-level viremia), elevated EBNA IgG and EBV EA-D IgG—markers of re-awakening or immune response to latent virus—were strongly correlated with new-onset fatigue and neurocognitive deficits, implicating an immune-mediated mechanism rather than ongoing lytic infection .
In short, EBV reactivation appears to act as a “second hit” after SARS-CoV-2, stoking neuro-inflammation and immune dysregulation that drive the memory, attention, and processing-speed problems characteristic of Long-COVID brain fog .
What are the specific cognitive symptoms linked to EBV reactivation in Long-COVID?
EditCopy
Epstein-Barr virus reactivation neurocognitive effects
In Long-COVID, reactivation of Epstein–Barr virus (EBV) has been specifically linked to the following cognitive symptoms:
Memory deficits – difficulty forming new memories and retrieving stored information .
Impaired concentration and attention – trouble focusing, sustaining mental effort, or multitasking .
Slowed processing speed – tasks that were previously automatic take longer to complete .
General “brain fog” – a subjective sense of mental cloudiness, confusion, or haziness .
These neurocognitive manifestations occur even when active EBV replication (viremia) is no longer detectable, suggesting that the lingering immune response—not ongoing viral replication—is the primary driver of these symptoms .
Can you explain the immune response's role in these cognitive symptoms?
EditCopy
Epstein-Barr virus immune response Long-COVID cognitive impairment
When EBV reactivates in the context of Long-COVID, the immune response itself—rather than active viral replication—drives the cognitive symptoms. Key mechanisms include:
Neuro-inflammation via pro-inflammatory cytokines
Reactivation triggers release of TNF-a, IL-1ß, and IL-6, which can cross the compromised blood–brain barrier and activate microglia. This sustained neuro-inflammation disrupts synaptic plasticity and results in memory deficits, slowed processing speed, and brain-fog .CD8? T-cell dysregulation
EBNA3A and BZLF-1 viral peptides stimulate CD8? T-effector-memory CD45RA? (TEMRA) cells that secrete IFN-?, granzymes (GZMA), and perforin. These cytotoxic factors injure neurons and oligodendrocytes, directly correlating with poorer cognitive performance .Molecular mimicry & autoimmunity
EBV-encoded proteins (e.g., LMP1, EBNA-1) share epitopes with myelin and neuronal antigens, prompting autoantibodies that attack brain tissue and produce attention deficits and executive dysfunction .Kynurenine pathway activation
Microglial IDO-1, induced by EBV-triggered cytokines, shunts tryptophan toward quinolinic acid, an NMDA-receptor agonist that causes excitotoxicity, mitochondrial failure, and fatigue-related cognitive impairment .Immune exhaustion & impaired viral control
Chronic EBV antigen exposure leads to exhausted CD8? T cells, allowing persistent low-grade viral protein presence that perpetuates neuro-inflammation and cognitive decline .
Together, these immune-mediated processes explain why elevated EBV IgG (but not necessarily active viremia) predicts memory problems, concentration deficits, and brain-fog in Long-COVID
Can you explain the link between neuro-inflammation and cognitive decline?
EditCopy
neuro-inflammation cognitive impairment mechanisms
Neuro-inflammation drives cognitive decline through a multi-hit cascade that derails the molecular and cellular machinery required for learning, memory, and executive function:
Microglial & astrocytic over-activation
Persistent activation of microglia and reactive astrocytes releases IL-1ß, IL-6, and TNF-a, which:Impair hippocampal neurogenesis in the dentate gyrus, reducing the pool of new neurons needed for memory formation .
Trigger synaptic pruning and dendritic spine loss, directly weakening synaptic connectivity .
Blood–brain barrier (BBB) breakdown & peripheral leukocyte infiltration
Pro-inflammatory cytokines degrade tight-junction proteins (claudin-5, occludin), allowing peripheral immune cells to enter the brain and amplify neuro-toxicity . This further disrupts neurotransmission and cerebral blood flow, compounding cognitive deficits .Oxidative & excitotoxic stress
Activated glia generate ROS/RNS, which:Damage NMDA receptors and mitochondria, leading to impaired long-term potentiation (LTP)—the cellular basis of memory .
Promote tau hyper-phosphorylation and amyloid-ß aggregation, forming a vicious cycle that accelerates neuronal death .
Hippocampal circuitry disruption
Chronic neuro-inflammation shrinks hippocampal volume, reduces BDNF signaling, and shifts neuroglia toward a neurotoxic phenotype, resulting in inattention, impaired working memory, and slower processing speed .
In essence, neuro-inflammation undermines the hippocampus and synaptic plasticity, creating the core cognitive deficits seen in Long-COVID brain fog, depression, and neurodegenerative diseases .
What are the common treatments for neuro-inflammation?
Can you provide some examples of neurodegenerative diseases?
How can we prevent the effects of neuro-inflammation on the brain?
EditCopy
preventing effects of neuro-inflammation on the brain
Below is a concise, evidence-based overview that answers the three questions in sequence.
1. Common evidence-based treatments for neuro-inflammation
TableCopy
2. Key neurodegenerative diseases in which neuro-inflammation is a central driver
Alzheimer’s disease (AD)
Parkinson’s disease (PD)
Huntington’s disease (HD)
Amyotrophic lateral sclerosis (ALS)
Multiple sclerosis (MS)
In these disorders, chronically activated microglia and astrocytes perpetuate neuronal loss by releasing cytotoxic cytokines and reactive oxygen/nitrogen species .
3. Preventing or minimizing neuro-inflammatory brain damage
TableCopy
Because there are still no drugs that fully halt or reverse most neurodegenerative processes, early detection of inflammatory biomarkers combined with lifestyle and targeted anti-inflammatory interventions is currently the most practical preventive strategy .
How can we identify early signs of neuro-inflammation?
EditCopy
how to identify neuro-inflammation in early stages
Early signs of neuro-inflammation are often subtle and non-specific, so clinicians and patients have to look for clusters of cognitive, mood, sleep, and autonomic changes rather than a single red-flag symptom.
1. Subjective / Clinical Red-Flags
Persistent brain-fog – difficulty concentrating, slow processing speed, forgetfulness
Unexplained mood swings – anxiety, depression, irritability without obvious psychological trigger
Unrefreshing sleep or insomnia despite adequate hours in bed
Headaches / dizziness that do not respond to usual remedies
Post-exertional mental fatigue – cognitive crash after minimal mental or physical effort
Autonomic quirks – heart-rate spikes, temperature dysregulation, GI motility changes
2. Low-Cost Screening Tools
Validated questionnaires – Montreal Cognitive Assessment (MoCA), Patient Health Questionnaire-9 (PHQ-9), generalized-anxiety disorder-7 (GAD-7)
CNS Vital Signs or Cambridge Neuropsychological Test Battery (CANTAB) – 15-min computerized cognitive batteries that pick up micro-changes in processing speed and working memory before they are obvious clinically
3. Peripheral & Imaging Biomarkers
TableCopy
4. Practical Early-Detection Workflow
Symptom screen (questionnaire + patient history)
Basic labs – hs-CRP, CBC, thyroid panel, B12, vitamin-D
If positive or high-risk, add plasma GFAP or CSF sTREM2 plus 3-T MRI brain with DTI
Serial cognitive testing every 6–12 months to track trajectory
Because neuro-inflammation begins silently, the key is to act on clusters of mild, persistent cognitive or mood complaints rather than waiting for overt neurological deficits .
how often to check for early signs of neuro-inflammation
1. Most common symptoms of neuro-inflammation
Cognitive: persistent brain fog, forgetfulness, difficulty focusing, slowed information processing
Mood: anxiety, depression, irritability, mood swings without obvious cause
Sleep: unrefreshing sleep, insomnia, excessive daytime fatigue
Pain & autonomic: chronic headaches, dizziness, post-exertional malaise, irregular heart-rate or digestion
Sensory: sensitivity to light, sound, chemicals, or scents
These symptoms can be subtle and fluctuate, often mistaken for stress or aging .
2. How often should you screen for early signs?
Low-risk adults: a baseline cognitive questionnaire (MoCA or CNS Vital Signs) every 1–2 years during routine physicals.
High-risk groups (Long-COVID, autoimmune disease, chronic stress, family history):
– Every 6–12 months add hs-CRP, IL-6, or plasma GFAP.
– If new cognitive or mood symptoms develop, move to same-day blood + neurocognitive testing.Red-flag triggers (head injury, infection flare, major life stress): screen immediately and again in 3–6 months .
3. Lifestyle changes that prevent or dampen neuro-inflammation
TableCopy
Implementing these habits within 8–12 weeks measurably lowers systemic and neuro-inflammatory markers and improves cognitive endurance .
What are the specific tests for neuro-inflammation?
How can I manage stress to reduce neuro-inflammation?
Can you suggest a healthy diet to prevent neuro-inflammation?
EditCopy
healthy diet for neuro-inflammation prevention
Below is a concise, evidence-based summary.
Specific tests that clinicians use to detect or monitor neuro-inflammation
• Blood – high-sensitivity CRP, ESR, IL-6, TNF-a, auto-antibody panels (ANA, anti-ds-DNA, anti-S100B, anti-claudin-5)
• CSF – cell count, protein, oligoclonal bands (OCBs), albumin quotient (blood–CSF barrier), antineuronal antibodies (anti-NMDA-R, anti-GFAP, anti-MOG)
• Imaging – MRI with FLAIR and DTI sequences, FDG-PET, TSPO-PET for microglial activation
• Functional assays – Array 20 (blood–brain-barrier permeability), cognitive testing (MoCA, CNS Vital Signs), EEG power analysis
In routine practice, the first-tier screen is usually blood CRP + auto-antibodies; second-tier is CSF analysis if symptoms or imaging are suggestive.
How to manage stress to curb neuro-inflammation
• Daily mindfulness – 10–15 min of guided meditation or box-breathing lowers IL-6 and TNF-a
• Regular movement – 150 min/week moderate cardio (brisk walking, cycling) and 2 strength sessions reduce microglial priming
• Sleep hygiene – 7–9 h nightly, address sleep-apnea; poor sleep raises CSF IL-1ß
• Cognitive–behavioral therapy (CBT) or biofeedback for chronic anxiety or trauma
• Social connection – weekly meaningful social interaction boosts oxytocin and dampens stress-induced cytokine releaseA simple anti-neuro-inflammatory diet (start with one meal at a time)
• Include daily:
– Fatty fish (salmon, sardines) or 1,000 mg EPA/DHA supplement
– 7–9 cups colorful plants (berries, leafy greens, cruciferous veg)
– Extra-virgin olive oil (2–3 Tbsp)
– Fermented foods (sauerkraut, kefir) for gut–brain axis support
• Eliminate or minimize: gluten, added sugar, trans-fats, ultra-processed foods, excessive alcohol, caffeine
• Flavor with: turmeric (curcumin + piperine), ginger, garlic, fresh herbs
• Hydration: 30–35 mL water/kg body weight daily; include broths and “wet” foods for glycine and collagen
Follow the “one-meal-at-a-time” plan (breakfast ? dinner ? lunch ? snacks) so the shift is sustainable.
Below are concise, evidence-based answers to the three follow-up questions.
1. Role of turmeric (curcumin) in reducing neuro-inflammation
Curcumin, the active polyphenol in turmeric, crosses the blood–brain barrier and down-regulates key inflammatory pathways:
• Inhibits NF-?B, thereby lowering TNF-a, IL-1ß, IL-6 and IL-18
• Reduces reactive astrogliosis (GFAP density) and microglial activation
• Prevents tau hyper-phosphorylation and amyloid aggregation driven by chronic neuro-inflammation
Bioavailability is limited, so formulations such as solid-lipid curcumin (Longvida) or micellar curcumin are preferred in clinical studies .
2. How regular movement specifically lowers neuro-inflammation
• Microglial polarization: aerobic exercise shifts microglia from a pro-inflammatory (M1) to a protective (M2) phenotype
• Cytokine reduction: 150 min/week of moderate-intensity activity lowers plasma and CSF levels of TNF-a, IL-6, and CRP within 8–12 weeks
• Neurotrophic boost: increases BDNF and cerebral blood flow, supporting synaptic repair and neuroplasticity
• Glymphatic clearance: rhythmic muscle contractions enhance cerebrospinal-fluid flow, flushing neuro-toxic debris
3. Fermented foods that strengthen the gut–brain axis
TableCopy
Aim for 1–2 servings daily, rotating varieties to maximize microbial diversity .
SOME QUESTIONS ANSWERED AND SOME NOT
What does the presence of HHV-6 IgG/IgM indicate?
How does EBV reactivation relate to cognitive symptoms in Long-COVID?
Could you explain the role of molecular mimicry in neuro-autoimmunity?
What should I do if I suspect HHV-6 reactivation?
How can I prevent HHV-6 reactivation?
What are the treatment options for HHV-6 reactivation?
What are the specific cognitive symptoms linked to EBV reactivation in Long-COVID?
How can we prevent EBV reactivation in post-COVID patients?
Are there any treatments currently being tested to mitigate EBV-related cognitive symptoms?
What other symptoms are associated with EBV reactivation in Long-COVID?
Can you explain the immune response's role in these cognitive symptoms?
Are there any treatments for these cognitive symptoms caused by EBV reactivation?
How does EBV reactivation affect the blood-brain barrier?
Can you explain the link between neuro-inflammation and cognitive decline?
What are the common treatments for neuro-inflammation?
Can you provide some examples of neurodegenerative diseases?
How can we prevent the effects of neuro-inflammation on the brain?
What are the specific roles of microglia in neurodegenerative diseases?
How can we identify early signs of neuro-inflammation?
Are there any new treatments being developed for neuro-inflammation?
What are the most common symptoms of neuro-inflammation?
How often should we get checked for early signs of neuro-inflammation?
Are there any lifestyle changes that can help prevent neuro-inflammation?
What are the specific tests for neuro-inflammation?
How can I manage stress to reduce neuro-inflammation?
Can you suggest a healthy diet to prevent neuro-inflammation?
